← All diseases
Cancer
Esophageal cancer
Do you want to be notified when there is new research about Esophageal Cancer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence above each publication explains what was studied — and you'll be notified as soon as new research on Esophageal Cancer is available. View what Premium costs.
Publications and studies (2611)
- GM-CSF and IL-21-armed oncolytic vaccinia virus significantly enhances anti-tumor activity and synergizes with anti-PD1 immunotherapy in pancreatic cancer. (2025/01/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. LncRNA HOXA10-AS as a novel biomarker and therapeutic target in human cancers. (2025/01/03) ♡
- Endoscopic negative-pressure treatment: From management of complications to pre-emptive active reflux drainage in abdomino-thoracic esophageal resection-A new safety concept for esophageal surgery. (2025/01/01) ♡
- Vitamin B12 Intake and Cancer Risk: Findings from a Case-Control Study in Vietnam. (2025/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Calf circumference-albumin index significantly predicts the prognosis of older patients with cancer cachexia: A multicenter cohort study. (2025/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Nutritional support via feeding jejunostomy in esophago-gastric cancers: proposal of a common working strategy based on the available evidence. (2025/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Global Leadership Initiative in Sarcopenia (GLIS) -defined sarcopenia increases the mortality of esophageal cancer patients after esophagectomy: A Chinese real-world cohort study. (2025/01/01) ♡
- Indices of healthy and unhealthy plant-based diets and the risk of selected digestive cancers. (2025/01/01) ♡
- A web-based tool for cancer risk prediction for middle-aged and elderly adults using machine learning algorithms and self-reported questions. (2025/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Impact of APOBEC3s on the occurrence, development and prognosis of esophageal squamous cell carcinoma. (2025/01/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Network Pharmacology Analysis and In Vitro Validation of the Active Ingredients and Potential Mechanisms of Gynostemma Pentaphyllum Against Esophageal Cancer. (2025/01/01) ♡
- Mechanism of Modified Tongyou Decoction and Its Separated Formulas Inhibiting Vasculogenic Mimicry in Esophageal Cancer TE-1 Cells via NF-κB/HIF-1α Axis. (2025/01/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Prevention and Treatment of Radiation-Induced Esophagitis With Oral Herbal Medicine: A Systematic Review and Meta-Analysis. (2025/01/01) ♡
- [Prediction of cervical anastomosis failure after McKeown esophagectomy]. (2025/01/01) ♡
- Association of energy expenditure with body composition and nutritional intake in male patients with esophageal and head and neck cancer. (2025/01/01) ♡
- Nutritional support in the comprehensive management of cutaneous squamous cell carcinoma in congenital epidermolysis bullosa. (2025/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Target-specific ImmunoPet Imaging of Digestive System Carcinoma (2025-12-31) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Nimotuzumab, Camrelizumab, and Neoadjuvant Chemotherapy（nCt）in the Treatment of Esophageal Squamous Cell Carcinoma (2025-12-31) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. [68Ga] Ga-FAPI PET/CT in Gastric and Gastroesophageal Junctional Cancer (2025-12-30) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors (2025-12-29) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Sintilimab Combined With Chemotherapy Induction Therapy Followed by CCRT vs. CCRT for Esophageal Cancer: A Randomized Controlled Phase Clinical Study (2025-12-29) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. PET-imaging of Two Vartumabs in Patients With Solid Tumors (2025-12-29) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Impact of Endo-vac Therapy for Esophago-Jejunal Anastomotic Leak (2025-12-29) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors (2025-12-24) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Aceto-whitening in the Assessment of Gastrointestinal Neoplasia (2025-12-24) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Value of Indocyanin Green-guided Near-infrared Fluorescence Technology in Tracing Sentinel Lymph Nodes During Esophagectomy (2025-12-24) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors. (2025-12-24) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Determinants of Patient Delay in Doctor Consultation in OECD Gastric Cancers (2025-12-23) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Objective is to Respond to Patients' Needs in the Field of Laryngeal Replacement (2025-12-22) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastroesophageal Cancer (2025-12-22) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the Oesophagus and Oesophagogastric Junction (2025-12-22) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma (2025-12-19) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy (2025-12-19) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Johns Hopkins Heartburn Center Registry (2025-12-18) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Family Caregiver Online Survey (Dementia and Swallowing Difficulties) (2025-12-18) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma (2025-12-18) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy as the First-line Treatment for Esophageal Squamous Cell Carcinoma (2025-12-17) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A) (2025-12-17) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Esophageal Carcinoma (2025-12-16) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Chemoradiotherapy for Advanced Esophageal Cancer (2025-12-16) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. EsophaCap for the Detection of Early Esophageal Carcinoma (2025-12-16) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. QL1706 Plus Chemotherapy for Borderline Resectable Esophageal Cancer (2025-12-16) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors (2025-12-15) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia (2025-12-12) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma (2025-12-12) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study of MT-4561 in Patients With Various Advanced Solid Tumors (2025-12-11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Feasibility Study CORPPS (2025-12-11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma (2025-12-11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype (2025-12-10) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Phase II Study of Toripalimab Plus Chemotherapy and Low-Dose Radiotherapy for Neoadjuvant Therapy-Refractory Esophageal Squamous Cell Carcinoma (2025-12-09) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.